Eero Saksela | Academic Influence

Eero Saksela's AcademicInfluence.com Rankings

Eero Saksela

Biology

#7570

World Rank

#10512

Historical Rank

Anatomy

#45

World Rank

#223

Historical Rank

Pathology

#158

World Rank

#283

Historical Rank

biology Degrees

Download Badge

Biology

Eero Saksela's Degrees

Doctorate Medicine University of Helsinki

Why Is Eero Saksela Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Eero Juhani Saksela is a Finnish professor of medicine. He was born in Helsinki. He became a physician and took his medical doctorate in 1962. Having been chief physician at the Helsinki University Central Hospital, he was a professor of pathological anatomy at the University of Helsinki from 1981 to 2001.

(See a Problem?)

Eero Saksela's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Isolation of human NK cells by density gradient centrifugation. (1980) (442)
Two established in vitro cell lines from human mesenchymal tumours (1967) (333)
Morphological and Functional Characterization of Isolated Effector Cells Responsible for Human Natural Killer Activity to Fetal Fibroblasts and to Cultured Cell Line Targets (1979) (269)
Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. (1979) (267)
Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. (1991) (263)
Transformation of cultures of human tissue infected with simian virus SV40. (1962) (248)
ANEUPLOIDY IN THE DEGENERATIVE PHASE OF SERIAL CULTIVATION OF HUMAN CELL STRAINS. (1963) (191)
c‐Myc induces cellular susceptibility to the cytotoxic action of TNF‐alpha. (1994) (153)
Human Natural Killer Cell Activity is Augmented by Interferon via Recruitment of ‘Pre‐NK’ Cells (1979) (141)
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer. (2002) (141)
Ultrastructure of human natural killer cells: nature of the cytolytic contacts in relation to cellular secretion. (1982) (130)
Induction of TNF‐sensitive cellular phenotype by c‐Myc involves p53 and impaired NF‐κB activation (1997) (120)
Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tissues. (1988) (118)
Enhancement of secondary constrictions and the heterochromatic X in human cells. (1962) (117)
NON-RANDOM CHROMOSOMAL ABERRATIONS IN SV 40-TRANSFORMED HUMAN CELLS. (1963) (113)
Natural killer cells are responsible for the interferon production induced in human lymphocytes by tumor cell contact (1980) (111)
Polarization of NK cell cytoskeleton upon conjugation with sensitive target cells. (1983) (107)
The cytotoxic activity of human natural killer cells requires an intact secretory apparatus. (1981) (92)
Human natural cell-mediated cytotoxicity against fetal fibroblasts. III. Morphological and functional characterization of the effector cells. (1979) (90)
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer. (2000) (86)
Heat shock protects WEHI‐164 target cells from the cytolysis by tumor necrosis factors α and β (1989) (82)
Cytological and functional analysis of inflammatory infiltrates in human malignant tumors II. Functional investigations of the infiltrating inflammatory cells (1978) (81)
Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon (1993) (81)
Are “natural killer” cells involved in allograft rejection? (1983) (80)
Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors. Circulating levels and tissue localization (1978) (79)
Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin‐fixed paraffin sections (1994) (72)
Parotid clear‐cell adenoma of possible myoepithelial origin (1972) (68)
Vaginal polyps with pseudosarcomatous features: A clinicopathologic study of seven cases (1983) (67)
The sequence of chromosome aberrations during SV 40 transformation of a human diploid cell strain. (2009) (67)
Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-α (1990) (62)
Monocyte is the main producer of human leukocyte alpha interferons following Sendai virus induction. (1984) (57)
TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer (2006) (57)
Transmission and spread of embryonic induction. II. Exclusion of an assimilatory transmission mechanism in kidney tubule induction. (1971) (57)
Tumor‐specific membrane antigens in established cell lines from gliomas (1974) (57)
Genital Chlamydia trachomatis Infections in Patients with Cervical Atypia (1979) (55)
[Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver]. (1972) (54)
Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. III. Further functional investigations using cultured autochthonous tumor cell lines and freeze-thawed infiltrating inflammatory cells. (1980) (53)
Expression of intermediate filaments in ovarian and uterine tumors. (1983) (51)
Human natural cell-mediated cytotoxicity against fetal fibroblasts. I. General characteristics of the cytotoxic activity. (1977) (48)
Analysis of collagen isotypes in crystalloid structures of salivary gland tumors. (1992) (47)
Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union—an inter-laboratory study (2004) (47)
THE EFFECT OF 5-BROMODEOXYURIDINE ON HUMAN CHROMOSOMES. (1964) (46)
C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer. (2002) (43)
A simplified isotope release assay for cell-mediated cytotoxicity against anchorage dependent target cells. (1977) (43)
Fibronectin facilitates the migration of human natural killer cells (1991) (42)
Cell-bound antiglial immunity in patients with malignant tumors of the brain. (1973) (41)
Involvement of beta 2-integrins in the migration of human natural killer cells. (1992) (38)
Malignant mesenchymal tumors of the uterine corpus. (1974) (37)
Activation of Natural Killer Cell Migration by Leukocyte Integrin-binding Peptide from Intracellular Adhesion Molecule-2 (ICAM-2) (*) (1995) (37)
Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell. (1986) (37)
Genital chlamydial infections in patients attending a gynaecological outpatient clinic. (1978) (34)
Swainsonine, an Inhibitor of Glycoprotein Processing, Enhances Cytotoxicity of Large Granular Lymphocytes (1990) (33)
Characterization of the E-selectin ligand on NK cells. (1994) (33)
Bacterial induction of human activated lymphocyte killing and its inhibition by lipopolysaccharide (LPS). (1986) (31)
The malignancy of mixed tumors of the parotid gland. A clinicopathological analysis of 70 cases. (1970) (30)
COLPOSCOPIC AND HISTOLOGICAL FINDINGS IN CERVICAL CHLAMYDIAL INFECTION (1980) (28)
Umbilical‐Cord‐Blood‐Derived Suppressor Cells of the Human Natural Killer Cell Activity Are Inhibited by Interferon (1982) (27)
Cytopathogenicity of cytomegalovirus to human ecto- and endocervical epithelial cells in vitro. (1975) (27)
Tumour microvessel density as predictor of chemotherapy response in breast cancer patients (2002) (27)
Teratogenic hazards of oral contraceptives analyzed in a national malformation register. (1981) (27)
The relationship of Sendai virus-induced chromosome pulverization to cell cyclus in HeLa cells. (2009) (26)
Misdiagnosis of prepubertal malignant melanoma. Reclassification of a cancer registry material (1968) (25)
Tumor necrosis factor-α and interferon-γ inhibit insulin-like growth factor II gene expression in human fetal adrenal cell cultures (1993) (25)
Suppression of human natural killer cell activity by amino sugars. (1989) (24)
The presence of concanavalin‐a(C0N‐A)‐like molecules on natural‐killer (NK)‐Sensitive target cells: Their possible role in swainsonine‐augmented human NK cytotoxicity (1992) (23)
Human natural cell-mediated cytotoxicity against fetal fibroblasts. II. Isolation and target cell specificity of the effector cells. (1978) (23)
Cancer of the anus and anal canal. (1970) (23)
Clinical and virological findings in patients with cytologically diagnosed gynecologic herpes simplex infections. (1977) (22)
Stromal reactions as prognostic factors in epidermoid carcinoma of the tongue. (1973) (22)
Specifically cytotoxic human and mouse lymphoid cells induced with antibody or antigen-antibody complexes. (1975) (22)
Two types of antibody dependent cell-mediated cytotoxicity, arming and sensitization. (1976) (21)
[Interferon and natural killer cells]. (1980) (21)
Ectopic pregnancy. Relationship to the preceding contraception. (1978) (21)
Cell-mediated cytotoxicity against HeLa cells in patients with invasive or preinvasive cervical cancer. (1973) (20)
Effect of a monoclonal anti-large granular lymphocyte antibody on the human NK activity. (1982) (20)
Identification of the effector cells in human blood displaying spontaneous cytotoxicity to chicken erythrocytes (1977) (19)
Primary carcinoma of Bartholin's glands: a morphological and clinical study of six cases including a transitional cell carcinoma. (1978) (19)
Monoclonal antibody defining a human syncytiotrophoblastic polypeptide immunologically related to mammalian retrovirus structural protein p30. (1984) (19)
Rheumatoid factor as an indicator of serum blocking activity and tumour recurrences in bladder tumours. (1976) (19)
Susceptibility of human chromosomes to pulverization induced by myxoviruses. (2009) (19)
Mechanism of cell contact-mediated inhibition of natural killer activity. (1987) (19)
Heat shock protects WEHI-164 target cells from the cytolysis by tumor necrosis factors alpha and beta. (1989) (18)
Glia-specific antigens in cell cultures from rabbit brain, human foetal and adult brain, and gliomas. (2009) (18)
A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation. (1984) (18)
Malignant mixed Müllerian tumor of the fallopian tube: report of a case with 5-year survival. (1983) (18)
Heat shock inhibits the cytotoxic action of TNF-alpha in tumor cells but does not alter its noncytotoxic actions in endothelial and adrenal cells. (1991) (18)
Tumor necrosis factor-alpha and interferon-gamma inhibit insulin-like growth factor II gene expression in human fetal adrenal cell cultures. (1993) (18)
Cell-mediated anti-embryo cytotoxicity in human pregnancy. (1976) (17)
A shared antigenic specificity of human large granular lymphocytes and precursors of NK-like and allospecific cytotoxic effector cells. (1984) (17)
XO-XY CHROMOSOME MOSAICISM. (1963) (17)
Chromosomal damage of human cells induced by Sendai virus. (1965) (17)
Deacetylase activity of human tumor cells producing immunosuppressive aminosugars: its possible role in resistance to cell-mediated cytotoxicity. (1993) (16)
Mr75,000 PROTEIN, A TUMOR MARKER IN RENAL ADENOCARCINOMA, REACTING WITH ANTIBODIES TO A SYNTHETIC PEPTIDE BASED ON A CLONED HUMAN ENDOGENOUS RETROVIRAL NUCLEOTIDE SEQUENCE (1985) (16)
Colposcopic and Histologic Findings in Cervical Chlamydial Infection (1982) (16)
Human Natural Killer Cells Express Different Integrins and Spread on Fibronectin (1991) (16)
A HeLa cell clonal line lacking alkaline phosphatase activity. (1960) (16)
Cheilitis granulomatosa--the Melkersson-Rosenthal syndrome. (1973) (16)
c-Myc and E1A induced cellular sensitivity to activated NK cells involves cytotoxic granules as death effectors (1999) (15)
Suppressor cells of natural killer activity in normal and tumor-bearing individuals. (1983) (15)
Spontaneous, augmentable cell‐mediated cytotoxicity with limited target cell specificity in human blood (1977) (15)
Characteristics of Soluble Tumour‐Derived Proteins That Inhibit Natural Killer Activity (1988) (14)
Virological studies on chromosome damage of HeLa cells induced by myxoviruses. (1966) (14)
Chromosomal changes of immunoglobulin-producing cell lines from human lymph nodes with and without lymphoma. (1968) (14)
‘Nonspecific’Blocking of Human Ovarian Carcinoma‐Associated Cellular Cytotoxicity In Vitro (1974) (14)
Suppressor cells of the human NK activity: characterization of the cells and mechanism of action. (1983) (14)
Directed exocytosis in the NK-cell-mediated cytotoxicity. A review. (1988) (13)
Identification and localization of urokinase‐type plasminogen activator in human NK‐cells (1986) (13)
MORPHOLOGY AND SURFACE PROPERTIES OF HUMAN NK CELLS (1980) (13)
Human NK Cells Expressing α4β1/β7 Adhere to VCAM‐1 Without Preactivation (1994) (13)
Cytological aspiration biopsy in otorhinolaryngological practice. A preliminary report with special reference to method. (1969) (13)
Further studies on the growth controlling action of human serum on cells cultivated in vitro. The chromosomal number of HeLa cells in active and heat-inactivated serum. (1960) (12)
Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase (1991) (12)
Comparison of areas of quinacrine mustard fluorescence and modified Giemsa staining in human metaphase chromosomes. (1972) (12)
NK‐9, a distinct sialylated antigen of the T200 family (1986) (12)
Non-specific binding of mouse immunoglobulins by swollen-bodied astrocytes — a potential source of confusion in human brain immunohistochemistry (2004) (11)
Growth behaviour of human brain tumours in matrix cultures in fresh autologous serum. (2009) (11)
Banding characteristics of paracentric marker constrictions in human chromosomes. (2009) (11)
Chronic perianal pyoderma--a study of the clinical and histogenetic features. (1969) (11)
The phenotype of human triploidy. (1974) (11)
Antibody‐Dependent Cell‐Mediated Cytotoxicity in Various Orders of Vertebrates (1977) (11)
Prognostic markers in epithelial ovarian cancer. (1993) (11)
Induction of Autologous Reactivity of Human NK Cells (1980) (10)
Chromosome heterogeneity of cell lines in vitro. 1. Differences in the effect of individual human sera on the chromosome number of HeLa cells. (2009) (10)
REGULATION OF HUMAN NATURAL KILLER ACTIVITY BY INTERFERON (1980) (10)
[What is good research?]. (1995) (9)
Common precursor pool marker for allospecific (CTL) and nonspecific (NK and activated) cytotoxic cells in the bone marrow. (1985) (9)
Myxoma of the external auditory meatus (1991) (8)
Growth of human brain tumour explants in matrix cultures in different human sera. (2009) (8)
Grand Rounds: Unilateral Lesions of the False Cord (1976) (8)
Adhesion Molecules Involved in the Interaction of LGL/NK Cells and Human Endothelial Cells Stimulated with Salmonella Bacteria (1992) (8)
Virilizing ovarian leiomyoma: androgen production by lining stromal cells (1996) (8)
Choriocarcinoma: Expression of tumor‐ and trophoblast‐associated antigens in patients with low chorionic gonadotropin excretion (1976) (7)
Interleukin‐2‐stimulated natural killer activity against malignant and benign endometrium (1987) (7)
Toluidine blue staining in the endoscopic diagnosis of carcinoma of the bronchus. (1972) (7)
Further characterization of the effector cell responsible for natural cytotoxicity to chicken erythrocytes in man (1978) (7)
Chromosome heterogeneity of cell lines in vitro. II. Report of a clonal line of the strain HeLa with numerous giant cells. (2009) (7)
Tumor necrosis factor in the human fetoplacentary unit. (1989) (7)
Blocking Effect of Rheumatoid Factor on the In Vitro Cytotoxicity of Lymphoid Cells from Carcinoma Patients (1976) (7)
The effect of different human sera on the karyologic picture of HeLa cells. A contribution to the knowledge of environmental influences on cell populations. (1962) (7)
Effect of preoperative radiotherapy on the growth of human renal carcinoma tissue in vitro. (1973) (7)
Pigmented villonodular synovitis and plasmacytoid lymphoma in a dog. (1990) (6)
Effect of Salmonella Bacteria on the Interaction of Human NK Cells with Endothelial Cells (1991) (5)
Chromosome heterogeneity of cell lines in vitro. 3. The effect of individual fresh human sera on the mitosis of HeLa cells. (2009) (5)
Advances in immunohistochemistry of ovarian tumours. (1989) (5)
Human NK cells expressing alpha 4 beta 1/beta 7 adhere to VCAM-1 without preactivation. (1994) (5)
Occurrence of Genital Herpes Simplex and Cytomegalovirus Infections in Pregnancy (1977) (4)
A guinea pig's view on prostate cancer screening trials. (1998) (4)
Increased number of functionally defective large granular lymphocytes in lymphoma patients. (1987) (4)
N‐α‐Benzyloxycarbonyl‐l‐Lysine Thiobenzyl Ester (BLT) Serine Esterase in Human Cytolytic Effector Cells and Cell Line Targets (1989) (4)
CELLULAR SECRETION ASSOCIATED WITH HUMAN NATURAL KILLER CELL ACTIVITY (1982) (4)
Chromosome aberrations induced by x-ray therapy and myxovirus infection in human peripheral leukocytes. (1970) (3)
Immunohistochemical Markers of Yolk Sac Tumors (1993) (3)
A sub‐set of immediate early mRNAs induced by tumor necrosis factor‐α during cellular cytotoxic and non‐cytotoxic responses (1993) (3)
Reduction by OK-432 of the monolayer contact-mediated inhibition of human natural killer cell activity. (1990) (3)
Induction of latent Herpes simplex virus type 2 infection in human cervical epithelial cells in vitro. (2009) (2)
Occurrence of genital herpes simplex and cytomegalovirus infections in pregnancy. (1977) (2)
Adenovirus infection and cytopathic alterations of human cervical epithelial cells in vitro. (1978) (2)
Variation of the chromosome number and anomalous mitoses in HeLa cells. (1962) (2)
INVOLVEMENT OF THE CYTOSKELETON AND AN ASSOCIATED 95 KD PROTEIN IN RECOGNITION AND LYSIS BY NK CELLS1 (1985) (2)
Inositol Phosphates and Calcium in the Cytolysis Mediated by NK and LAK Cells (1989) (2)
Clonal pattern of metastasis in a case of malignant mucoepidermoid tumour of the palatal salivary gland. (1971) (2)
Choriocarcinoma: expression of tumor- and trophoblast-associated antigens in patients with low chorionic gonadotropin excretion. (1976) (2)
ADVANCES IN THE IMMUNOHISTOCHEMISTRY OF OVARIAN TUMORS (1987) (1)
EARLY MORPHOLOGY OF THE CHROMOSOME DAMAGE INDUCED BY SENDAI VIRUS (2009) (1)
Growth pattern of meningeomas penetrating the skull base. (1972) (1)
SUPPRESSOR LYMPHOCYTES OF HUMAN NK CELL ACTIVITY (1982) (1)
Does an induced cell induce another cell (1971) (1)
Condyloma acuminatum giganticum: Buschke-Loewenstein tumour. (1970) (1)
Clinical follow-up and the cell-mediated cytotoxicity against HeLa cells in patients with invasive or preinvasive cervical cancer. (1976) (0)
[Joint pains, neurological symptoms and hypergammaglobulinemia]. (1997) (0)
[Prostate cancer screening]. (1997) (0)
[External factors and the genome]. (1968) (0)
Potentiation ofHumanNatural Killer CellCytotoxicity by Salmonella Bacteria Isan Interferon- andInterleukin-2-In (1991) (0)
[Immunodiagnostics of neoplasms]. (1974) (0)
Molecular Mechanisms Controlling Susceptibitliy to Tumor Necrosis Factor Induced Cell Death (1996) (0)
Teaching and continuing education in pathology. (1981) (0)
International Society of Gynecological Pathologists, Atlanta, Georgia, Sunday, February 27, 1983 (1982) (0)
[Genetics in vitro]. (1968) (0)
Cyst fluid of glioma does not inhibit the killing action of lymphokine-activated killer (LAK) cellsin vitro (2005) (0)
Pregnancy during convalescence from cytomegalovirus mononucleosis. (1972) (0)
Interleukin-2 activated lymphocytes (LAK cells) as potential tumor tracers. (1990) (0)
[CHROMOSOMES AND MALIGNANCY]. (1963) (0)
[Complex mechanics of tumor-necrosis-factor-induced cell death]. (1992) (0)
[Glomus jugular tumors]. (1972) (0)
[Cancer is a souvenir from the RNA world]. (2005) (0)
[Biological background of paraneoplastic phenomena]. (1978) (0)
[The Fernström prize to Kari Cantellille]. (1981) (0)
[Inevitable senile death]. (2014) (0)
[Prostate cancer and medical ethics]. (1997) (0)
[Immunoblastic lymphadenopathy]. (1979) (0)
[New drugs for cancer treatment]. (2004) (0)
[An eye for morphology in the medical profession]. (1997) (0)
[Prognosis of malignant melanoma]. (1968) (0)
[Postgraduate training in medical research]. (1986) (0)
[New immunological dimensions of apoptosis]. (1997) (0)
[Nucleic acids and genetics. Summary]. (1965) (0)
CHORIOCARCINOMA: EXPRESSION OF TUMOR- AND TROPHOBLAST-ASSOCIATED ANTIGENS IN PATIENTS WITH LOW CHORIONIC GONADOTROPIN EXCRETION (1977) (0)
Malignant histiocytosis. A clinical and morphological study of four cases. (1978) (0)
TheKidneyandIntravascular Coagulation inMyelomatosis (1974) (0)
[Natural killer cells and tumor resistance]. (1983) (0)
Ovarian Pathology (1989) (0)
Erkki Saxén 75 years old (1996) (0)
[Virus and lymphoma]. (1970) (0)
Monocyte independent secretion of leukocyte migration inhibitory factor by human natural killer cells (1984) (0)
HRO:sta gerasteniaan (2015) (0)
[Cellular control mechanism]. (1975) (0)
[Not Available]. (2007) (0)
[Is death biologically inevitable?]. (2003) (0)
[Matti Ayräpää Award to Matti Haltia]. (2002) (0)
Morphology of the premalignant lesions of the breast. (1993) (0)
[Will the human genome deteriorate?]. (1981) (0)

This paper list is powered by the following services:

Other Resources About Eero Saksela

en.wikipedia.org

What Schools Are Affiliated With Eero Saksela?

Eero Saksela is affiliated with the following schools:

University of Helsinki